Cargando…
Atypical antipsychotics for Parkinson’s disease psychosis: a systematic review and meta-analysis
PURPOSE: To assess the present evidence regarding the efficiency, safety, and potential risks of pharmacotherapy used for Parkinson’s disease psychosis (PDPsy) treatment. PATIENTS AND METHODS: We searched the following databases: PubMed, the Cochrane Library, ISI Web of Science, and Embase using the...
Autores principales: | Zhang, Han, Wang, Limin, Fan, Yafei, Yang, Lianhong, Wen, Xiaojun, Liu, Yunyun, Liu, Zhonglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677378/ https://www.ncbi.nlm.nih.gov/pubmed/31551655 http://dx.doi.org/10.2147/NDT.S201029 |
Ejemplares similares
-
Antipsychotics for the management of psychosis in Parkinson's disease: systematic review and meta-analysis
por: Jethwa, Ketan Dipak, et al.
Publicado: (2015) -
Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study
por: Yuan, Mei, et al.
Publicado: (2017) -
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong, Zhuoyuan, et al.
Publicado: (2017) -
Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis
por: Mousavi, Seyed Ghafur, et al.
Publicado: (2013) -
Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges
por: Waddington, John L.
Publicado: (2020)